Silver Book Fact

Value of smallpox eradication

An estimated $100 million spent in eradicating smallpox from 1967 to 1977 saved the world around $1.35 billion a year.

Barrett S. Eradication Versus Control: The economics of global infectious disease policies. Bulletin of the WHO. 2004; 82: 683-8. http://www.who.int/bulletin/volumes/82/9/683.pdf

Reference

Title
Eradication Versus Control: The economics of global infectious disease policies
Publication
Bulletin of the WHO
Publication Date
2004
Authors
Barrett S
Pages
683-8
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Economic Value

Related Facts

  • Economic value from flu vaccine in elderly
    As over 60% of the economic burden of influenza falls on those ages 65 and older, programs to reduce the impact of influenza on older Americans would have the greatest…  
  • Influenza vaccine use reduces antibiotic use
    Use of LAIV (live attenuated influenza virus) in healthy adults ages 18 to 65 reduced antibiotic use by 43% to 47%.  
  • Cost-effectiveness of flu vaccine
    Vaccination for pandemic influenza (pH1N1) prior to an outbreak produces incremental cost-effectiveness ratios for individuals without high risk conditions, ranging from $8,000 to $52,000 per quality-adjusted life year.  
  • Vaccines cost ~$50 per healthy life year saved
    Most vaccinations cost less than $50 per healthy life year saved. In contrast, treating hypertension costs between $4,340 and $87,940 per healthy life year saved.  
  • Vaccines in development 2013
    137 vaccines are currently in development in the U.S. for infectious diseases.